| Results of Operations, Depreciation and Amortization Expenses by Reportable Segments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended April 3, 2026 |
|
|
|
Automation Enabling Technologies |
|
|
Medical Solutions |
|
|
Total |
|
|
Revenue |
$ |
131,244 |
|
|
$ |
126,463 |
|
|
$ |
257,707 |
|
|
Cost of revenue |
|
67,292 |
|
|
|
71,730 |
|
|
|
|
|
Amortization of purchased intangible assets |
|
1,201 |
|
|
|
2,558 |
|
|
|
|
|
Segment gross profit |
|
62,751 |
|
|
|
52,175 |
|
|
|
114,926 |
|
|
Research and development and engineering |
|
9,033 |
|
|
|
14,247 |
|
|
|
|
|
Selling, general and administrative |
|
19,888 |
|
|
|
16,307 |
|
|
|
|
|
Amortization of purchased intangible assets |
|
2,119 |
|
|
|
3,655 |
|
|
|
|
|
Restructuring, acquisition, and related costs |
|
563 |
|
|
|
1,240 |
|
|
|
|
|
Segment operating income |
|
31,148 |
|
|
|
16,726 |
|
|
|
47,874 |
|
|
Unallocated costs |
|
— |
|
|
|
— |
|
|
|
(20,335 |
) |
|
Interest income (expense), net |
|
— |
|
|
|
— |
|
|
|
(1,843 |
) |
|
Other income (expense), net |
|
— |
|
|
|
— |
|
|
|
658 |
|
|
Income before income taxes |
$ |
31,148 |
|
|
$ |
16,726 |
|
|
$ |
26,354 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 28, 2025 |
|
|
|
Automation Enabling Technologies |
|
|
Medical Solutions |
|
|
Total |
|
|
Revenue |
$ |
123,167 |
|
|
$ |
110,199 |
|
|
$ |
233,366 |
|
|
Cost of revenue |
|
62,422 |
|
|
|
62,036 |
|
|
|
|
|
Amortization of purchased intangible assets |
|
1,359 |
|
|
|
2,202 |
|
|
|
|
|
Segment gross profit |
|
59,386 |
|
|
|
45,961 |
|
|
|
105,347 |
|
|
Research and development and engineering |
|
9,439 |
|
|
|
13,955 |
|
|
|
|
|
Selling, general and administrative |
|
19,159 |
|
|
|
14,732 |
|
|
|
|
|
Amortization of purchased intangible assets |
|
2,408 |
|
|
|
3,146 |
|
|
|
|
|
Restructuring, acquisition, and related costs |
|
(3,109 |
) |
|
|
99 |
|
|
|
|
|
Segment operating income |
|
31,489 |
|
|
|
14,029 |
|
|
|
45,518 |
|
|
Unallocated costs |
|
— |
|
|
|
— |
|
|
|
(13,097 |
) |
|
Interest income (expense), net |
|
— |
|
|
|
— |
|
|
|
(5,644 |
) |
|
Other income (expense), net |
|
— |
|
|
|
— |
|
|
|
(359 |
) |
|
Income before income taxes |
$ |
31,489 |
|
|
$ |
14,029 |
|
|
$ |
26,418 |
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
April 3, |
|
|
March 28, |
|
Depreciation and Amortization Expenses |
2026 |
|
|
2025 |
|
Automation Enabling Technologies |
$ |
4,199 |
|
|
$ |
5,476 |
|
Medical Solutions |
|
9,577 |
|
|
|
7,679 |
|
Unallocated |
|
384 |
|
|
|
408 |
|
Total |
$ |
14,160 |
|
|
$ |
13,563 |
|
|
|
|
|
|
|
|
|
|
April 3, |
|
|
December 31, |
|
|
2026 |
|
|
2025 |
|
Accounts Receivable |
|
|
|
|
|
Automation Enabling Technologies |
$ |
80,671 |
|
|
$ |
76,685 |
|
Medical Solutions |
|
93,263 |
|
|
|
108,195 |
|
Total accounts receivable |
$ |
173,934 |
|
|
$ |
184,880 |
|
Inventories |
|
|
|
|
|
Automation Enabling Technologies |
$ |
114,541 |
|
|
$ |
110,205 |
|
Medical Solutions |
|
78,602 |
|
|
|
78,079 |
|
Total inventories |
$ |
193,143 |
|
|
$ |
188,284 |
|
Total segment assets |
$ |
367,077 |
|
|
$ |
373,164 |
|
|
| Schedule of Geographic Revenue |
The Company aggregates geographic revenue based on the customer locations where products are shipped to. Revenue by geography was as follows (in thousands):
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
April 3, |
|
|
March 28, |
|
|
2026 |
|
|
2025 |
|
United States |
$ |
122,014 |
|
|
$ |
123,646 |
|
Germany |
|
36,294 |
|
|
|
28,477 |
|
Rest of Europe |
|
42,240 |
|
|
|
31,781 |
|
China |
|
23,549 |
|
|
|
21,434 |
|
Rest of Asia-Pacific |
|
27,389 |
|
|
|
23,379 |
|
Other |
|
6,221 |
|
|
|
4,649 |
|
Total |
$ |
257,707 |
|
|
$ |
233,366 |
|
|